Franklin Resources
ANIP icon

Franklin Resources’s ANI Pharmaceuticals ANIP Stock Holding History

Franklin Resources’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Sell
4,023
-11,995
-75% -$962K ﹤0.01% 2699
2026
Q1 		$1.23M Sell
16,018
-203
-1% -$15.8K ﹤0.01% 2095
2025
Q4 		$1.28M Sell
16,221
-18
-0.1% -$1.56K ﹤0.01% 1979
2025
Q3 		$1.49M Buy
16,239
+543
+3% +$44.3K ﹤0.01% 1908
2025
Q2 		$1.02M Buy
15,696
+3,514
+29% +$229K ﹤0.01% 1985
2025
Q1 		$816K Buy
12,182
+9
+0.1% +$538 ﹤0.01% 2059
2024
Q4 		$673K Buy
12,173
+116
+1% +$6.66K ﹤0.01% 2164
2024
Q3 		$705K Buy
12,057
+691
+6% +$42.2K ﹤0.01% 2132
2024
Q2 		$724K Buy
11,366
+2,799
+33% +$182K ﹤0.01% 2074
2024
Q1 		$592K Buy
8,567
+652
+8% +$39.4K ﹤0.01% 2171
2023
Q4 		$436K Sell
7,915
-71
-0.9% -$3.91K ﹤0.01% 2009
2023
Q3 		$464K Buy
7,986
+576
+8% +$33.2K ﹤0.01% 1954
2023
Q2 		$399K Buy
+7,410
New +$328K ﹤0.01% 2075

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's ANIP Position: Q2 2026 in Review

Franklin Resources reduced its ANI Pharmaceuticals (ANIP) stake by 75% in Q2 2026, selling an estimated $962K and leaving 4,023 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #2699.

Franklin Resources first reported a position in ANIP in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.49M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Franklin Resources held 4,023 shares of ANI Pharmaceuticals worth $333K as of Q2 2026.
  • Franklin Resources sold 11,995 ANI Pharmaceuticals shares in Q2 2026, an estimated $962K.
  • ANI Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2699 holding.
  • Franklin Resources first reported a position in ANI Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Franklin Resources's ANI Pharmaceuticals position peaked at $1.49M in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.